Screening and Analysis of the Marker Components in Ganoderma lucidum by HPLC and HPLC-MSn with the Aid of Chemometrics
- PMID: 28383512
- PMCID: PMC6154496
- DOI: 10.3390/molecules22040584
Screening and Analysis of the Marker Components in Ganoderma lucidum by HPLC and HPLC-MSn with the Aid of Chemometrics
Abstract
Ganoderma triterpenes (GTs) are the major secondary metabolites of Ganoderma lucidum, which is a popularly used traditional Chinese medicine for complementary cancer therapy. The present study was to establish a fingerprint evaluation system based on Similarity Analysis (SA), Cluster Analysis (CA) and Principal Component Analysis (PCA) for the identification and quality control of G. lucidum. Fifteen samples from the Chinese provinces of Hainan, Neimeng, Shangdong, Jilin, Anhui, Henan, Yunnan, Guangxi and Fujian were analyzed by HPLC-PAD and HPLC-MSn. Forty-seven compounds were detected by HPLC, of which forty-two compounds were tentatively identified by comparing their retention times and mass spectrometry data with that of reference compounds and reviewing the literature. Ganoderic acid B, 3,7,15-trihydroxy-11,23-dioxolanost-8,16-dien-26-oic acid, lucidenic acid A, ganoderic acid G, and 3,7-oxo-12-acetylganoderic acid DM were deemed to be the marker compounds to distinguish the samples with different quality according to both CA and PCA. This study provides helpful chemical information for further research on the anti-tumor activity and mechanism of action of G. lucidum. The results proved that fingerprints combined with chemometrics are a simple, rapid and effective method for the quality control of G. lucidum.
Keywords: Ganoderma lucidum; HPLC-MSn; Similarity Analysis (SA); chemometrics; triterpenes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






References
-
- Bojana B. Ganoderma lucidum: A potential for biotechnological production of anti-cancer and immunomodulatory drugs. Recent Pat. Anticancer Drug Discov. 2013;8:255–287. - PubMed
-
- Xia Q., Zhang H.Z., Sun X.F., Zhao H.J., Wu L.F., Zhu D., Yang G.H., Shao Y.Y., Zhang X.X., Mao X., et al. A comprehensive review of the structure elucidation and biological activity of triterpenoids from Ganoderma spp. Molecules. 2014;19:17478–17535. doi: 10.3390/molecules191117478. - DOI - PMC - PubMed
-
- Feng L., Yuan L., Du Y., Chen Y., Zhang M.H., Gu J.F., He J.J., Wang Y., Cao W. Anti-Lung cancer activity through enhancement of immunomodulation and induction of cell apoptosis of total triterpenes extracted from Ganoderma luncidum (Leyss. ex Fr.) Karst. Molecules. 2013;18:9966–9981. doi: 10.3390/molecules18089966. - DOI - PMC - PubMed
-
- Huang S.M., Yang X.L., Wang B.W., Zhu H.S., Xu J.L. Antitumor activity of ethanol-soluble and acidic components from Ganoderma lucidum. Nat. Prod. Res. 2004;16:146–148.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials